GSNOR and ALDH2 alleviate traumatic spinal cord injury
- 1 May 2021
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1758, 147335
- https://doi.org/10.1016/j.brainres.2021.147335
Abstract
No abstract availableKeywords
Funding Information
- US Department of Veterans Affairs
- National Institutes of Health
This publication has 50 references indexed in Scilit:
- Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammationBMC Pulmonary Medicine, 2014
- Regulation by S-Nitrosylation of Protein Post-translational ModificationOnline Journal of Public Health Informatics, 2012
- Mechanism of Inhibition for N6022, a First-in-Class Drug Targeting S-Nitrosoglutathione ReductaseBiochemistry, 2012
- A combined scoring method to assess behavioral recovery after mouse spinal cord injuryNeuroscience Research, 2010
- Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variantNature Structural & Molecular Biology, 2010
- Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impactJournal of Neuroinflammation, 2009
- Pharmacological evidence for a role of peroxynitrite in the pathophysiology of spinal cord injuryExperimental Neurology, 2009
- The Janus face of alcohol dehydrogenase 3Chemico-Biological Interactions, 2009
- Acrolein‐mediated mechanisms of neuronal deathJournal of Neuroscience Research, 2006
- Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve LigationJournal of Neuroscience, 2004